Published guidance, NICE advice and quality standards | Guidance

Showing 661 to 670 of 2422

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Immunoscore for predicting risk of colon cancer relapse	MIB269	3 August 2021	3 August 2021
Nivolumab with ipilimumab for previously treated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency	TA716	28 July 2021	28 July 2021
Inducing and maintaining normothermia using temperature modulation devices to improve outcomes after stroke or subarachnoid haemorrhage	IPG701	28 July 2021	28 July 2021
Clostridioides difficile infection: antimicrobial prescribing	NG199	23 July 2021	23 July 2021
Duvelisib for treating relapsed follicular lymphoma after 2 or more systemic therapies (terminated appraisal)	TA717	21 July 2021	21 July 2021
Ixekizumab for treating axial spondyloarthritis	TA718	21 July 2021	21 July 2021
Secukinumab for treating non-radiographic axial spondyloarthritis	TA719	21 July 2021	21 July 2021
ENDURALIFE powered CRT-D devices for treating heart failure	MTG33	17 March 2017	21 July 2021
Dasatinib for treating Philadelphia-chromosome-positive acute lymphoblastic leukaemia (terminated appraisal)	TA714	14 July 2021	14 July 2021
Adalimumab, etanercept, infliximab and abatacept for treating moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	14 July 2021	14 July 2021